ARCHIVES

Cancer Center Directors to Develop Blueprint for Progress That’s “Honest,” M.D. Anderson’s John Mendelsohn Says.

This article is from The Cancer Letter archive.

Vol. 32 No. 42 | November 22, 2006

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Recommend Use of Cytokines GM-CSF, G-CSF In BMT And Chemotherapy

January 4, 1991

Solomon Gard Loses Final Cancer Battle

February 12, 1982

Research teams link response to Iressa to mutations in EGF receptor.

April 30, 2004

NCI Agrees To Offer New Screening RFP In The Future

May 28, 1976

Managed Care Limits Access To Trials, Cancer Panel Says

August 11, 1995

Retrospective Data Clean-up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”

March 8, 2002